Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Calithera selects oral arginase inhibitor CB-1158 as immuno-oncology clinical candidate

June 26, 2015

Western Oncolytics closes financing round to advance cancer immunotherapy

June 26, 2015

Encouraging first-in-human data obtained with BI-836826 in CLL

June 25, 2015

Vaxil's ImMucin designated FDA orphan drug for multiple myeloma

June 23, 2015

New round of funding to support Batu Biologics' development of ValloVax

June 23, 2015

European Commission approves Opdivo for advanced melanoma

June 22, 2015

TapImmune gains additional funding

June 22, 2015

Pembrolizumab receives U.S. orphan drug status for gastric cancer

June 22, 2015

Admune Therapeutics starts phase I trial of hetIL-15 in metastatic cancers

June 19, 2015

OncoSec Medical starts phase II study of ImmunoPulse in HNSCC

June 19, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...